MyJournals Home  

RSS FeedsProteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients (Pharmacogenomics Journal)

 
 

10 december 2019 05:04:24

 
Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients (Pharmacogenomics Journal)
 




 
249 viewsCategory: Genomics, Pharmacology
 
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients (Pharmacogenomics Journal)
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer (Pharmacogenomics Journal)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten